Returning irregular migrants: Is deportation the UK's only option?

Article

Irregular migration presents a significant public and policy concern across the EU and in particularly in the UK, where the estimated number of irregular migrants is one of the highest in the EU.

We are currently working on forthcoming case studies on the experiences of irregular migrants returning to Morocco and Nigeria from Europe. Based on in-depth qualitative interviews involving over 100 returnees in both countries, we will be investigating how we could ensure more effective policy responses to the return and reintegration of these migrants. In advance of this in-depth IPPR research, we are publishing two short briefings.

Returning irregular migrants: Is deportation the UK's only option? examines the current situation in the UK, where there is no systematic policy of amnesty or regularisation for irregular migrants. With the aim of addressing some of the questions around improving return management, we highlight the limitations in the current UK's response which relies heavily on the forced removal of irregular migrants.

The ultimate goal is to seek an efficient and sustainable approach to returning irregular migrants to their home countries.

Related items

  1. A female carer pushes an older female wheelchair user along a path in a residential area on a sunny day

    Who will care?: How can we meet the scale of the care challenge?

    Progressives need to see a better future for care: as a functioning, reliable and affordable public service.
  2. Entrance sign at the Foreign, Commonwealth and Development office in Westminster

    Reset: Building modern partnerships with the countries of the global south

    The UK's relationships with many countries of the ‘global south’ are in a poor state.
  3. Doctor with patient for consultation, medical advice or procedure at clinic

    Taken to heart: Inequalities in heart disease in Scotland

    More than 7.6 million people across the UK live with cardiovascular disease (CVD), around twice as many as live with Alzheimer’s disease and cancer combined.